The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ratain, Mark J.
One or more keywords matched the following items that are connected to Ratain, Mark J.
Item TypeName
Concept Randomized Controlled Trials as Topic
Academic Article Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing?
Academic Article Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article EGFR pharmacogenomics: the story continues to mutate and evolve.
Academic Article Hairy cell leukemia. Current management.
Academic Article Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
Academic Article Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies.
Academic Article Optimising the design of phase II oncology trials: the importance of randomisation.
Academic Article Bar the windows but open the door to randomization.
Academic Article Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Academic Article Randomized phase II trials: a long-term investment with promising returns.
Academic Article Individualizing dosing of irinotecan.
Academic Article Might cigarettes be a "smoking gun" to reduce taxane myelotoxicity?
Academic Article Meaningful use of pharmacogenetics.
Academic Article Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.
Academic Article The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care.
Academic Article Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.
Academic Article Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.
Search Criteria
  • Trials Randomized Clinical